Research Management Group (RMG)

California Institute for Regenerative Medicine (CIRM)
CIRM 13-04 External Innovation Pilot Program


CIRM funding opportunity- letters of intent are accepted anytime. The objective of this RFA is to catalyze the collaboration between California researchers and researchers external to California. This program would provide funding for key personnel in California to join existing innovative external studies in order to accelerate those studies towards clinical applications. (Please see PI and Project eligibility.)


Guidelines- CIRM webpage >>


Timeline:

Deadline: Letters of intent accepted anytime via their online grants management portal
Full proposal (by invitation only)
Because this program could encompass different types of projects, specific review criteria and application forms may vary. If CIRM invites an applicant to submit a Full Application, CIRM will provide application forms and instructions that are appropriate to the type of project proposed.

Amount of funding: up to $500K direct costs per year for 12-36 months
This RFA is targeted at only the most exceptional proposals. CIRM expects to support only one or two such projects per year.


Program
The objective of this RFA is to catalyze the collaboration between California researchers and researchers external to California. This program would provide funding for key personnel in California to join innovative external studies in order to accelerate those studies towards clinical applications.

This RFA is intended to capture uniquely promising opportunities that cannot be addressed through CIRM’s other funding programs. The program will be focused on new collaborations that:


Eligibility:


Project Eligibility:


Project Scope

The scope of the proposed collaboration should be consistent with CIRM’s scientific priorities:

 

Evaluation of the Letter of Intent

Evaluation of an LOI will consider two primary criteria: Whether the external collaboration is critical to the proposal, and whether the proposed research is novel and transformative. The external collaboration would be considered critical if the project depends on unique expertise, methods, technologies or resources that are offered by the external collaborator, and unlikely to be available within California.

Assessment of the proposed research will be based on the type of work proposed:

 

 

Stanford Medicine Resources:

Footer Links: